CFDE Data Portal | Search PARGP1

	Label	Description
	PARGP1 associations Collection (Entity type)	Associations for PARGP1_associations
	PARGP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PARGP1 Gene (Entity type)	ENSG00000290921 - PARG pseudogene 1
	GSE111247 temozolomide LN-308 2 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE249544 GSE249637 temozolomide 9 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115550 BRD4 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 trametinib NF1 10 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS

PARGP1 associations

Associations for PARGP1_associations

PARGP1 associations.tsv

A file from IDG as part of the Harmonizome project

PARGP1

ENSG00000290921 - PARG pseudogene 1

GSE111247 temozolomide LN-308 2 v 13 human up

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

GSE249544 GSE249637 temozolomide 9 v 7 human up

A Gene Set from LINCS

GSE115550 BRD4 inhibition 2 v 1 human up

A Gene Set from LINCS

GSE120612 etoposide leukocyte 4 v 2 human dn

A Gene Set from LINCS

GSE102505 tunicamycin 6 v 2 human up

A Gene Set from LINCS

GSE213588 trametinib NF1 10 v 12 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.